Our mission is to explore the medical and pharmaceutical potential in compounds from our products, derived from an innovative hydrolysis technology. In the years to come we are confident – and research from some of the world leading university and hospitals clearly indicates – that our technology could become the basis of tomorrow's medicine
Research is ongoing in multiple clinics and university research labs in several countries. Lead clinical and pre-clinical candidates are development towards treatment for asthma/Covid19-patients and Gastro-Intestinal (GI) Protective Medical Food. The research also indicates therapeutic effects on the conditions age-related sarcopenia, anemia and NEC-IBD.
In addition to the potential in becoming the medicine of tomorrow, HBC has an established industry that develops high-value ingredients and finished products for the nutrition market. Our products are present in 40 different countries throughout the world.
The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources.
Hofseth BioCare's headquarters are in Ålesund, Norway with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
The technology and research is proprietary to our company.